By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
EEG biosensor is a technique for capturing an electrogram of the brain’s spontaneous electrical activity. It has been demonstrated that the biosignals picked up by EEG are postsynaptic potentials of pyramidal neurons in the neocortex and allocortex. The International 10-20 system, or variants of it, is commonly used to implant the EEG electrodes along the scalp, making it a minimally invasive procedure.
The term “intracranial EEG” is occasionally used to refer to electrocorticography, which involves surgically implanting electrodes. Visual inspection of the trace or quantitative EEG analysis are the two methods used most frequently in clinical interpretation of EEG recordings.
The EEG bioamplifier and electrodes’ voltage measurements enable the assessment of typical brain activity. The recordings made by the electrodes on the scalp’s surface vary depending on their direction and proximity to the source of the electrical activity, which is a group of neurons in the underlying brain tissue.
Moreover, intermediate tissues and bone, which behave similarly to resistors and capacitors in an electrical circuit, affect the value reported. This indicates that not all neurons will contribute equally to an EEG signal, with an EEG mostly reflecting the activity of cortical neurons close to the scalp electrodes.
The base of the cortical gyrus, the mesial walls of the main lobes, the hippocampus, the thalamus, and the brainstem are deep brain areas that are farther from the electrodes and do not immediately contribute to an EEG.
The Global EEG biosensor market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Leading consumer neurotechnology and meditation company Interaxon Inc. haslaunched the release of their VR Software Development Kit and a new EEG biosensor headband that is compatible with all popular VR head-mounted displays and is based on Interaxon’s Muse S second-generation EEG meditation & sleep headband.
Using their award-winning biosensing technology in VR and AR applications, Interaxon hopes to offer strategic partnership prospects for advancements in brain health with this launch. The integration of biosensor data from wearables into digital health experiences has provided consumers with new levels of personalized insights.
Moving toward a more integrated future where personalized recommendations are unified across a variety of wellness applications, Interaxon believes web3 has the potential to create a more streamlined approach to digital health and data management for end-users that also leverages real-time biofeedback for powerful wellness interventions.
The rise in telehealth services amid the pandemic, for example, presents an opportunity for biosensor data and real-time biofeedback to be utilized to transform the digital health and wellness space by improving the overall remote healthcare experience for providers and users alike.
